BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34685756)

  • 1. The Involvement of Macrophage Colony Stimulating Factor on Protein Hydrolysate Injection Mediated Hematopoietic Function Improvement.
    Wang S; Zhang Y; Meng W; Dong Y; Zhang S; Teng L; Liu Y; Li L; Wang D
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calf thymus polypeptide improved hematopoiesis via regulating colony-stimulating factors in BALB/c mice with hematopoietic dysfunction.
    Li L; Jiang X; Teng S; Zhang L; Teng L; Wang D
    Int J Biol Macromol; 2020 Aug; 156():204-216. PubMed ID: 32156537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcodon imbricatus polysaccharides improve mouse hematopoietic function after cyclophosphamide-induced damage via G-CSF mediated JAK2/STAT3 pathway.
    Wang X; Chu Q; Jiang X; Yu Y; Wang L; Cui Y; Lu J; Teng L; Wang D
    Cell Death Dis; 2018 May; 9(6):578. PubMed ID: 29784961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic effects and mechanisms of Fufang e׳jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice.
    Liu M; Tan H; Zhang X; Liu Z; Cheng Y; Wang D; Wang F
    J Ethnopharmacol; 2014 Mar; 152(3):575-84. PubMed ID: 24534527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
    Kaur S; Sehgal A; Wu AC; Millard SM; Batoon L; Sandrock CJ; Ferrari-Cestari M; Levesque JP; Hume DA; Raggatt LJ; Pettit AR
    J Hematol Oncol; 2021 Jan; 14(1):3. PubMed ID: 33402221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
    Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.
    Shalit I; Kletter Y; Halperin D; Waldman D; Vasserman E; Nagler A; Fabian I
    Eur J Haematol; 2001 May; 66(5):287-96. PubMed ID: 11422407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
    Kovacs CJ; Evans MJ; Daly BM; Thomas-Patterson D; Johnke RM; Powell DS
    J Interferon Cytokine Res; 1997 Aug; 17(8):453-60. PubMed ID: 9282825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
    Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
    Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO; Schneider JG; Moore MA
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.
    Quesniaux VF; Wehrli S; Steiner C; Joergensen J; Schuurman HJ; Herrman P; Schreier MH; Schuler W
    Blood; 1994 Sep; 84(5):1543-52. PubMed ID: 7520778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human macrophage-colony stimulating factor on marrow, splenic, and peripheral hematopoietic progenitor cells in mice.
    Yamauchi T; Yada K; Umemura A; Asakura E; Hanamura T; Tanabe T
    J Leukoc Biol; 1996 Feb; 59(2):296-301. PubMed ID: 8604003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of granulocyte-colony stimulating factor and macrophage-colony stimulating factor on recovery of donor hematopoietic cells in allogeneic bone marrow transplantation.
    Zhang Y; Adachi Y; Suzuki Y; Minamino K; Iwasaki M; Nakano K; Koike Y; Mukaide H; Shigematsu A; Kiriyama N; Li C; Ikehara S
    Oncol Rep; 2006 Aug; 16(2):367-71. PubMed ID: 16820917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.
    Keller JR; Gooya JM; Ruscetti FW
    Blood; 1996 Aug; 88(3):863-9. PubMed ID: 8704242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
    Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
    Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.